Clinical Trial Update: Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing cilostazol dexborneol versus placebo for microcirculation dysfunction after reperfusion therapy in acute ischemic stroke with l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• cilostazol dexborneol (cilostazol dexborneol)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke, Reperfusion | Phase 2 | Status: UNKNOWN